Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Zolbetuximab |
Trade Name | |
Synonyms | IMAB362|Claudiximab |
Drug Descriptions |
Zolbetuximab (IMAB362) is a monoclonal antibody that binds to the tight junction molecule CLDN18.2, thereby blocking proliferation of tumor cells (PMID: 23900716, PMID: 26811601, PMID: 31240302). |
DrugClasses | CLDN18.2 Antibody 15 |
CAS Registry Number | 1496553-00-4 |
NCIT ID | C85475 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Capecitabine + Oxaliplatin + Zolbetuximab | Capecitabine Oxaliplatin Zolbetuximab | 0 | 2 |
Fluorouracil + Leucovorin + Oxaliplatin + Zolbetuximab | Fluorouracil Leucovorin Oxaliplatin Zolbetuximab | 0 | 3 |
Gemcitabine + Nab-paclitaxel + Zolbetuximab | Gemcitabine Nab-paclitaxel Zolbetuximab | 0 | 1 |
Pembrolizumab + Zolbetuximab | Pembrolizumab Zolbetuximab | 0 | 1 |
Zolbetuximab | Zolbetuximab | 0 | 1 |